Delivery Order SPE2DB24D1107-SPE2DB25FZFZ7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,632.89 to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count packages). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 23, 2025, with performance at the vendor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly prescribed for type 2 diabetes management, reflecting the critical pharmaceutical supply needs...
- The Defense Logistics Agency awarded a delivery order valued at $5,240.80 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This firm fixed price delivery order represents a non-competitive procurement and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used in military and federal healthcare systems to...
- The Defense Logistics Agency awarded a delivery order valued at $21,234.32 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Jardiance is a prescription medication used in diabetes management,...
- The Defense Logistics Agency awarded a delivery order valued at $6,888.31 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This competitive delivery order, which carries a firm fixed price structure and includes no set-aside designation, will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a widely prescribed medication for type 2 diabetes management,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $14,137.08. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is scheduled for ultimate completion on July 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a medication...
- The Defense Logistics Agency awarded a delivery order valued at $5,392.64 to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and is being fulfilled from the contractor's place of business in Conshohocken, Pennsylvania. Jardiance is a prescription medication used to manage type 2 diabetes, reflecting the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $29,954.01 on July 18, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price, competitively awarded contract represents a non-set-aside delivery order with an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes management medication, consistent with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,582.52 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and falls under the company's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Jardiance 10 mg tablets in a 90-count quantity, with a contract ceiling value of $11,538.19. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a ceiling value of $4,120.39. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by July 25, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Jardiance is a diabetes...
- SPE2DB24D1107Indefinite Delivery Contract
- SPE2DB24D1107-SPE2DB25FZFZ7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets in a 90-count package. This firm fixed-price delivery order, valued at $22,382.43, was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. The order will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. Jardiance is a diabetes medication commonly used to treat type 2 diabetes and is a standard pharmaceutical item within federal healthcare procurement portfolios serving military and veteran populations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to defense and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill complex medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.4k | 7/21/25 |